299 related articles for article (PubMed ID: 19789328)
21. Dihydrotanshinone I inhibits the translational expression of hypoxia-inducible factor-1α.
Li J; Mi C; Ma J; Wang KS; Lee JJ; Jin X
Chem Biol Interact; 2015 Oct; 240():48-58. PubMed ID: 26282490
[TBL] [Abstract][Full Text] [Related]
22. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
[TBL] [Abstract][Full Text] [Related]
23. Methylalpinumisoflavone inhibits hypoxia-inducible factor-1 (HIF-1) activation by simultaneously targeting multiple pathways.
Liu Y; Veena CK; Morgan JB; Mohammed KA; Jekabsons MB; Nagle DG; Zhou YD
J Biol Chem; 2009 Feb; 284(9):5859-68. PubMed ID: 19091749
[TBL] [Abstract][Full Text] [Related]
24. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
Li J; Xi W; Li X; Sun H; Li Y
Bioorg Med Chem; 2019 Apr; 27(7):1145-1158. PubMed ID: 30819620
[TBL] [Abstract][Full Text] [Related]
25. Obstructive sleep apnea syndrome promotes the progression of aortic dissection
Liu W; Zhang W; Wang T; Wu J; Zhong X; Gao K; Liu Y; He X; Zhou Y; Wang H; Zeng H
Int J Biol Sci; 2019; 15(13):2774-2782. PubMed ID: 31853217
[No Abstract] [Full Text] [Related]
26. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
[TBL] [Abstract][Full Text] [Related]
27. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
28. Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase.
Kim YH; Coon A; Baker AF; Powis G
Cancer Chemother Pharmacol; 2011 Aug; 68(2):405-13. PubMed ID: 21069338
[TBL] [Abstract][Full Text] [Related]
29. NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction.
Kim KH; Kim D; Park JY; Jung HJ; Cho YH; Kim HK; Han J; Choi KY; Kwon HJ
J Mol Med (Berl); 2015 May; 93(5):499-509. PubMed ID: 25471482
[TBL] [Abstract][Full Text] [Related]
30. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
Rapisarda A; Melillo G
Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
[TBL] [Abstract][Full Text] [Related]
31. Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
Fernandez EV; Reece KM; Ley AM; Troutman SM; Sissung TM; Price DK; Chau CH; Figg WD
Mol Pharmacol; 2015 Jun; 87(6):1006-12. PubMed ID: 25829060
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway.
Huang L; Zhang Z; Zhang S; Ren J; Zhang R; Zeng H; Li Q; Wu G
Int J Mol Med; 2011 Mar; 27(3):407-15. PubMed ID: 21249310
[TBL] [Abstract][Full Text] [Related]
33. Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor.
Okamoto K; Ito D; Miyazaki K; Watanabe S; Tohyama O; Yokoi A; Ozawa Y; Asano M; Kawamura T; Yamane Y; Nagao S; Funasaka S; Kamata J; Kotake Y; Aoki M; Tsukahara N; Mizui Y; Tanaka I; Sawada K
Int J Mol Med; 2012 Apr; 29(4):541-9. PubMed ID: 22211243
[TBL] [Abstract][Full Text] [Related]
34. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
35. Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1alpha in hypoxia.
Chen RQ; Yang QK; Chen YL; Oliveira VA; Dalton WS; Fearns C; Lee JD
J Biol Chem; 2009 Jun; 284(25):16752-16758. PubMed ID: 19406746
[TBL] [Abstract][Full Text] [Related]
36. FG-4592 Accelerates Cutaneous Wound Healing by Epidermal Stem Cell Activation via HIF-1α Stabilization.
Tang D; Zhang J; Yan T; Wei J; Jiang X; Zhang D; Zhang Q; Jia J; Huang Y
Cell Physiol Biochem; 2018; 46(6):2460-2470. PubMed ID: 29742498
[TBL] [Abstract][Full Text] [Related]
37. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
38. Small molecules targeting HIF-1α pathway for cancer therapy in recent years.
Tang W; Zhao G
Bioorg Med Chem; 2020 Jan; 28(2):115235. PubMed ID: 31843464
[TBL] [Abstract][Full Text] [Related]
39. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z; Fang J; Xia C; Shi X; Jiang BH
Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
[TBL] [Abstract][Full Text] [Related]
40. Mitoxantrone inhibits HIF-1α expression in a topoisomerase II-independent pathway.
Toh YM; Li TK
Clin Cancer Res; 2011 Aug; 17(15):5026-37. PubMed ID: 21653687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
